Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Earlier this month, we were delighted to welcome the Director of the Sir Jules Thorn Charitable Trust, Richard Benson, and its Chair of Trustees, Liz Charal.

Richard Benson and Liz Charal of the Sir Jules Thorn Charitable Trust

The Sir Jules Thorn Charitable Trust supports translational medical research as well as innovation and improvement in the wider healthcare sector. To mark its 50th anniversary in 2014, the Trust awarded a grant of £5 million to establish the Sir Jules Thorn Sleep and Circadian Neuroscience Institute (SCNi).

During their visit, Liz Charal and Richard Benson from the Trust met Professor Russell Foster and members of his research group. They were able to see SCNi space in full use, following the formal opening of the Dorothy Crowfoot Hodgkin Building last November. As part of the visit, we celebrated the recent installation of a new donor plaque and SCNi signage recognising the generous support of the Trust.

Thanks to the support of the Trust, the SCNi team are undertaking fundamental research into the mechanisms that generate and regulate circadian rhythms and sleep. They are translating these discoveries to develop different therapeutics to improve health and well-being across the health spectrum.



Similar stories

European Platform for Neurodegenerative Diseases launches repository of cohorts for researchers

The new Cohort Catalogue will facilitate discovery of over 60 neurodegeneration research cohorts from 17 countries across Europe

Two NDCN students join BNA Scholars Programme

The British Neuroscience Association Scholars Programme was launched in 2021 with a view to improving equality, diversity and inclusion in neuroscience.

Researchers win UK Dementia Research Institute Grand Challenge Award to identify early signs of Alzheimer's

The MRC Brain Network Dynamics Unit has received funding for a multi-year research partnership designed to advance the understanding of early changes to the operations of brain circuits in Alzheimer's disease.

Ophthalmology Conference in Kyiv

On 21 February, Robert MacLaren organised a one-day ophthalmology conference in Kyiv together with Dr Andrii Ruban, President of the Ukrainian Vitreoretinal Society.

Bioelectronic implant offers an intelligent therapy to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their 'smart' bioelectronic implants.

Direct evidence of reduced NMDA receptors in people with form of encephalitis

NMDAR-antibody encephalitis is an autoimmune brain condition caused by patient’s own antibodies that bind to NMDA (N-Methyl-D-Aspartate) receptors in the synapses between nerve cells.